Cardiovascular and Cerebrovascular Control in Healthy Subjects
Launched by IRCCS POLICLINICO S. DONATO · Jan 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Cardiovascular and Cerebrovascular Control in Healthy Subjects," is looking to understand how the body regulates blood flow and heart function in healthy individuals. The study will involve 30 participants who are between the ages of 18 and older. Researchers will record various bodily functions, such as heart rate and blood pressure, while subjects undergo a simple test where they change positions, like standing up from sitting. This will help scientists learn how the body manages blood flow to the brain and other areas during changes in posture.
To be eligible for this study, participants must be at least 18 years old, have a normal heart rhythm, and give their consent to join the trial. However, individuals with certain issues related to the autonomic nervous system, which controls involuntary body functions, will not be included. If you decide to participate, you can expect a straightforward process where your vital signs are monitored, helping researchers gather important information about how a healthy body functions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \>18
- • sinus rhythm
- • informed consent signed
- Exclusion Criteria:
- • age \<18
- • presence of autonomic nervous system diseases or dysfunctions
About Irccs Policlinico S. Donato
IRCCS Policlinico S. Donato is a leading Italian research hospital and clinical trial sponsor dedicated to advancing medical science through innovative research and patient care. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it is recognized for its commitment to high-quality clinical research and the integration of scientific investigation with clinical practice. The institution specializes in various medical fields, including cardiology, oncology, and neurology, and collaborates with universities and research organizations to facilitate cutting-edge studies. With a focus on improving patient outcomes and contributing to public health, IRCCS Policlinico S. Donato plays a pivotal role in the development of new therapies and treatment protocols.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Donato Milanese, Milan, Italy
San Donato Milanese, Lombardia, Italy
San Donato Milanese, Milan, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials